Clik here to view.
Hoffmann-La Roche asks for Accutane judge’s recusal
Drug maker Hoffmann- La Roche has asked for the recusal of the New Jersey judge overseeing the Accutane mass tort litigation, asserting that Judge Carol E. Higbee is siding unfairly with plaintiffs who...
View ArticleGeneric drug user can sue brand-name manufacturer
State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation, the Alabama Supreme Court has ruled in answering a certified question from a U.S....
View ArticlePfizer avoids Chantix bellwether trial with settlement
Pfizer has avoided a bellwether trial scheduled to begin this month in the Chantix multidistrict litigation by settling with an Alabama man who claimed he became suicidal after taking the...
View ArticlePropecia’s sexual side effects may be ‘irreversible,’ report says
Sexual side effects experienced by men taking the hair-loss drug Propecia may be permanent, according to a new report by a drug industry watchdog. The January QuarterWatch found evidence in Food and...
View ArticleMass. jury awards $63M for child’s reaction to Motrin
A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and...
View ArticleN.J. judge refuses to recuse herself from Accutane cases
The state judge overseeing Accutane mass tort litigation in New Jersey has denied Hoffmann- La Roche’s motion asking that she recuse herself. Atlantic County Superior Court Judge Carol E. Higbee flatly...
View ArticleRoche appeals, fights for new Accutane judge
Continuing in its efforts to find a new judge for the thousands of Accutane cases pending in New Jersey state court, Hoffman-La Roche filed notice to appeal a decision by presiding Judge Carol E....
View ArticleJustices look for line to draw in drug preemption case
WASHINGTON – Deciding where the preemptive effect of federal rules governing drug manufacturing ends and states’ ability to impose liability on drug makers begins has never been an easy task — not even...
View ArticleClik here to view.
Justices: Generic drug design-defect claims preempted
WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that impose a duty on generic drug makers to either change their labeling...
View ArticleClik here to view.
Generic drug preemption ruling a blow to plaintiffs
WASHINGTON – The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking...
View ArticleHoffmann-La Roche asks for Accutane judge’s recusal
Drug maker Hoffmann- La Roche has asked for the recusal of the New Jersey judge overseeing the Accutane mass tort litigation, asserting that Judge Carol E. Higbee is siding unfairly with plaintiffs who...
View ArticleGeneric drug user can sue brand-name manufacturer
State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation, the Alabama Supreme Court has ruled in answering a certified question from a U.S....
View ArticlePfizer avoids Chantix bellwether trial with settlement
Pfizer has avoided a bellwether trial scheduled to begin this month in the Chantix multidistrict litigation by settling with an Alabama man who claimed he became suicidal after taking the...
View ArticlePropecia’s sexual side effects may be ‘irreversible,’ report says
Sexual side effects experienced by men taking the hair-loss drug Propecia may be permanent, according to a new report by a drug industry watchdog. The January QuarterWatch found evidence in Food and...
View ArticleMass. jury awards $63M for child’s reaction to Motrin
A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and...
View ArticleN.J. judge refuses to recuse herself from Accutane cases
The state judge overseeing Accutane mass tort litigation in New Jersey has denied Hoffmann- La Roche’s motion asking that she recuse herself. Atlantic County Superior Court Judge Carol E. Higbee flatly...
View ArticleRoche appeals, fights for new Accutane judge
Continuing in its efforts to find a new judge for the thousands of Accutane cases pending in New Jersey state court, Hoffman-La Roche filed notice to appeal a decision by presiding Judge Carol E....
View ArticleJustices look for line to draw in drug preemption case
WASHINGTON – Deciding where the preemptive effect of federal rules governing drug manufacturing ends and states’ ability to impose liability on drug makers begins has never been an easy task — not even...
View ArticleJustices: Generic drug design-defect claims preempted
WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that impose a duty on generic drug makers to either change their labeling...
View ArticleGeneric drug preemption ruling a blow to plaintiffs
WASHINGTON – The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking...
View Article
